Galectin Therapeutics (GALT) Enterprise Value Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.47% |
| Dec 31, 2025 | 1.59% |
| Sep 30, 2025 | 10.04% |
| Jun 30, 2025 | 17.11% |
| Mar 31, 2025 | 38.28% |
| Sep 30, 2024 | 9.58% |
| Jun 30, 2024 | 6.78% |
| Mar 31, 2024 | -4.30% |
| Dec 31, 2023 | 1.85% |
| Sep 30, 2023 | 14.48% |
| Jun 30, 2023 | 23.90% |
| Mar 31, 2023 | 25.66% |
| Sep 30, 2022 | 32.00% |
| Jun 30, 2022 | 22.55% |
| Mar 31, 2022 | -65.50% |
| Sep 30, 2021 | -53.42% |
| Jun 30, 2021 | -44.39% |
| Mar 31, 2021 | -73.31% |
| Dec 31, 2020 | -107.16% |
| Sep 30, 2020 | -67.26% |
| Jun 30, 2020 | -64.69% |
| Mar 31, 2020 | -46.99% |
| Dec 31, 2019 | -45.66% |
| Sep 30, 2019 | -51.99% |
| Jun 30, 2019 | -47.41% |
| Mar 31, 2019 | 30.32% |
| Dec 31, 2018 | 30.04% |
| Sep 30, 2018 | 21.95% |
| Jun 30, 2018 | 26.43% |
| Mar 31, 2018 | 48.59% |
| Dec 31, 2017 | 52.85% |
| Sep 30, 2017 | 39.36% |
| Jun 30, 2017 | 35.76% |
| Mar 31, 2017 | 28.03% |
| Dec 31, 2016 | -13.56% |
| Sep 30, 2016 | -13.85% |
| Jun 30, 2016 | -47.15% |
| Mar 31, 2016 | -43.19% |
| Dec 31, 2015 | -37.04% |
| Sep 30, 2015 | -24.46% |
| Jun 30, 2015 | -26.16% |
| Mar 31, 2015 | -32.65% |
| Dec 31, 2014 | -90.05% |
| Sep 30, 2014 | -80.45% |
| Jun 30, 2014 | -81.25% |
| Mar 31, 2014 | -73.99% |
| Dec 31, 2013 | -35.38% |
| Sep 30, 2013 | -51.14% |
| Jun 30, 2013 | -21.21% |